you are viewing a single comment's thread.
VX-787 data by year end. Oh, and you're short a very volatile biotech because you saw a double doji. That's 2; the latter being the most persuasive.
VX-787... yes I do recall that data being due 1Q:2012, then it was mid year 2012, then it was 3Q:2012, now it is year end.
Typical Vertex never delivering on time.... add that to botched data release and it is no wonder they don't inspire Wall Street's confidence.
And in case you didn't read between the lines here... not delivering on time means their claim at reducing R&D expenses is fiction.
Not to mention that VX-787 is worthless to Vertex... no money to stockpile, no flu pandemic to stockpile for, etc.